JP2000287915A
(ja)
*
|
1999-04-08 |
2000-10-17 |
Machida Endscope Co Ltd |
手術用案内管装置
|
US7192713B1
(en)
|
1999-05-18 |
2007-03-20 |
President And Fellows Of Harvard College |
Stabilized compounds having secondary structure motifs
|
US6494865B1
(en)
*
|
1999-10-14 |
2002-12-17 |
Becton Dickinson And Company |
Intradermal delivery device including a needle assembly
|
US6843781B2
(en)
*
|
1999-10-14 |
2005-01-18 |
Becton, Dickinson And Company |
Intradermal needle
|
US6776776B2
(en)
|
1999-10-14 |
2004-08-17 |
Becton, Dickinson And Company |
Prefillable intradermal delivery device
|
US20020095134A1
(en)
*
|
1999-10-14 |
2002-07-18 |
Pettis Ronald J. |
Method for altering drug pharmacokinetics based on medical delivery platform
|
US20020193740A1
(en)
|
1999-10-14 |
2002-12-19 |
Alchas Paul G. |
Method of intradermally injecting substances
|
US20020156453A1
(en)
*
|
1999-10-14 |
2002-10-24 |
Pettis Ronald J. |
Method and device for reducing therapeutic dosage
|
US20020198509A1
(en)
*
|
1999-10-14 |
2002-12-26 |
Mikszta John A. |
Intradermal delivery of vaccines and gene therapeutic agents via microcannula
|
US8465468B1
(en)
|
2000-06-29 |
2013-06-18 |
Becton, Dickinson And Company |
Intradermal delivery of substances
|
US7241275B2
(en)
|
1999-10-14 |
2007-07-10 |
Becton, Dickinson And Company |
Intradermal needle
|
US6569123B2
(en)
|
1999-10-14 |
2003-05-27 |
Becton, Dickinson And Company |
Prefillable intradermal injector
|
US6569143B2
(en)
|
1999-10-14 |
2003-05-27 |
Becton, Dickinson And Company |
Method of intradermally injecting substances
|
DE19950530A1
(de)
*
|
1999-10-20 |
2001-06-13 |
Frank Neveling |
Spritze zur intrakutanen Injektion
|
US6537242B1
(en)
|
2000-06-06 |
2003-03-25 |
Becton, Dickinson And Company |
Method and apparatus for enhancing penetration of a member for the intradermal sampling or administration of a substance
|
US20050008683A1
(en)
*
|
2000-06-29 |
2005-01-13 |
Becton Dickinson And Company |
Method for delivering interferons to the intradermal compartment
|
US20040175360A1
(en)
*
|
2000-06-29 |
2004-09-09 |
Pettis Ronald J. |
Method for altering drug pharmacokinetics based on medical delivery platform
|
NL1016207C2
(nl)
*
|
2000-09-15 |
2002-03-18 |
Univ Erasmus |
Samenstel van een naald en een flu´dumtoevoerinrichting, alsmede een naald, een injectiespuit, een werkwijze voor het uitvoeren van een intraneurale punctie, en een werkwijze voor het voor intraneurale toediening voorbereiden van een inbrenginrichting.
|
GB0022742D0
(en)
|
2000-09-15 |
2000-11-01 |
Smithkline Beecham Biolog |
Vaccine
|
PT1361890E
(pt)
*
|
2001-02-23 |
2011-06-07 |
Glaxosmithkline Biolog Sa |
Formulações vacinais de influenza para distribuição intradérmica
|
EP1361889A1
(de)
*
|
2001-02-23 |
2003-11-19 |
GlaxoSmithKline Biologicals S.A. |
Neue vakzine
|
GB0109297D0
(en)
*
|
2001-04-12 |
2001-05-30 |
Glaxosmithkline Biolog Sa |
Vaccine
|
MXPA03009371A
(es)
*
|
2001-04-13 |
2004-11-12 |
Becton Dickinson Co |
Metodos y dispositivos para administrar sustancias en la capa intradermica de la piel para absorcion sistemica.
|
AU2002254558A1
(en)
*
|
2001-04-27 |
2002-11-11 |
Becton, Dickinson And Company |
Novel vaccine
|
TWI228420B
(en)
|
2001-05-30 |
2005-03-01 |
Smithkline Beecham Pharma Gmbh |
Novel vaccine composition
|
US20100221284A1
(en)
|
2001-05-30 |
2010-09-02 |
Saech-Sisches Serumwerk Dresden |
Novel vaccine composition
|
JP2004528939A
(ja)
*
|
2001-06-08 |
2004-09-24 |
イーライ・リリー・アンド・カンパニー |
薬剤注射器のための針隠蔽アセンブリー
|
US20050010193A1
(en)
*
|
2002-05-06 |
2005-01-13 |
Laurent Philippe E. |
Novel methods for administration of drugs and devices useful thereof
|
US20060018877A1
(en)
*
|
2001-06-29 |
2006-01-26 |
Mikszta John A |
Intradermal delivery of vacccines and therapeutic agents
|
US20040120964A1
(en)
*
|
2001-10-29 |
2004-06-24 |
Mikszta John A. |
Needleless vaccination using chimeric yellow fever vaccine-vectored vaccines against heterologous flaviviruses
|
WO2003041763A2
(en)
*
|
2001-11-14 |
2003-05-22 |
Medical Instill Technologies, Inc. |
Intradermal delivery device and method
|
WO2004069301A2
(en)
*
|
2003-01-30 |
2004-08-19 |
Becton, Dickinson And Company |
Intradermal delivery device with contoured skin engaging surface geometry
|
US20060264886A9
(en)
*
|
2002-05-06 |
2006-11-23 |
Pettis Ronald J |
Method for altering insulin pharmacokinetics
|
BR0311443A
(pt)
|
2002-05-06 |
2005-03-22 |
Becton Dickinson Co |
Método e dispositivo para controlar farmacocinética de droga
|
AU2003253859A1
(en)
*
|
2002-07-08 |
2004-01-23 |
Medical Instill Technologies, Inc. |
Interadermal delivery device, and method of intradermal delivery
|
CA2497086A1
(en)
*
|
2002-08-30 |
2004-03-11 |
Becton, Dickinson And Company |
Method of controlling pharmacokinetics of immunomodulatory compounds
|
ES2287517T3
(es)
*
|
2002-09-10 |
2007-12-16 |
Becton Dickinson And Company |
Metodo y aparato para la administracion epidermica de una sustancia.
|
US20040097882A1
(en)
|
2002-11-14 |
2004-05-20 |
Dibiasi Michael A. |
Self-aligning shield for syringe
|
EP1583423A4
(de)
*
|
2003-01-16 |
2006-05-10 |
Becton Dickinson Co |
Intradermale abgabe von zellen mittels dünner mikrokanüle
|
AU2004264839B2
(en)
*
|
2003-06-13 |
2009-06-04 |
Becton, Dickinson And Company |
Improved intra-dermal delivery of biologically active agents
|
AU2004270113A1
(en)
*
|
2003-08-26 |
2005-03-17 |
Becton, Dickinson And Company |
Methods for intradermal delivery of therapeutics agents
|
CA2536681C
(en)
|
2003-08-28 |
2011-07-05 |
Becton, Dickinson And Company |
Intradermal injection device
|
US20050054981A1
(en)
*
|
2003-09-04 |
2005-03-10 |
Romano Carlo Luca |
Auxiliary device for attenuating pain of injections, traumas, small lesions, hair removing operations, and inflammation conditions
|
ITMI20031706A1
(it)
*
|
2003-09-04 |
2005-03-05 |
Carlo Luca Romano' |
Dispositivo ausiliario per eseguire iniezioni.
|
AU2003270473A1
(en)
|
2003-09-09 |
2005-04-27 |
University Of Florida |
Desferrithiocin derivatives and their use as iron chelators
|
DK1680443T5
(en)
|
2003-11-05 |
2015-02-02 |
Dana Farber Cancer Inst Inc |
Stabilized alpha-helix peptides and uses thereof
|
US20050256499A1
(en)
*
|
2004-03-03 |
2005-11-17 |
Pettis Ronald J |
Methods and devices for improving delivery of a substance to skin
|
EP1744784A2
(de)
*
|
2004-05-11 |
2007-01-24 |
Becton, Dickinson and Company |
Schmerzmittelformulierungen und verfahren zu deren anwendung
|
US20080085289A1
(en)
|
2004-09-22 |
2008-04-10 |
Cindy Castado |
Immunogenic Composition
|
US9492400B2
(en)
|
2004-11-04 |
2016-11-15 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
PE20061428A1
(es)
|
2005-03-23 |
2007-01-16 |
Glaxosmithkline Biolog Sa |
Formulacion de vacuna que comprende un adyuvante de emulsion aceite en agua y 3d-mpl
|
EP1866296B1
(de)
|
2005-04-04 |
2016-11-02 |
University of Florida Research Foundation, Inc. |
Desferrithiocin-polyether-analoge
|
US20060264966A1
(en)
*
|
2005-05-12 |
2006-11-23 |
Med Institute, Inc. |
Vertebroplasty leak prevention sleeve and method
|
US9486274B2
(en)
|
2005-09-07 |
2016-11-08 |
Ulthera, Inc. |
Dissection handpiece and method for reducing the appearance of cellulite
|
US10548659B2
(en)
*
|
2006-01-17 |
2020-02-04 |
Ulthera, Inc. |
High pressure pre-burst for improved fluid delivery
|
US8518069B2
(en)
|
2005-09-07 |
2013-08-27 |
Cabochon Aesthetics, Inc. |
Dissection handpiece and method for reducing the appearance of cellulite
|
US9358033B2
(en)
|
2005-09-07 |
2016-06-07 |
Ulthera, Inc. |
Fluid-jet dissection system and method for reducing the appearance of cellulite
|
US9011473B2
(en)
|
2005-09-07 |
2015-04-21 |
Ulthera, Inc. |
Dissection handpiece and method for reducing the appearance of cellulite
|
US7842008B2
(en)
*
|
2005-11-21 |
2010-11-30 |
Becton, Dickinson And Company |
Intradermal delivery device
|
US7885793B2
(en)
|
2007-05-22 |
2011-02-08 |
International Business Machines Corporation |
Method and system for developing a conceptual model to facilitate generating a business-aligned information technology solution
|
US9248317B2
(en)
|
2005-12-02 |
2016-02-02 |
Ulthera, Inc. |
Devices and methods for selectively lysing cells
|
TWI457133B
(zh)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
US9267937B2
(en)
|
2005-12-15 |
2016-02-23 |
Massachusetts Institute Of Technology |
System for screening particles
|
GB0607088D0
(en)
|
2006-04-07 |
2006-05-17 |
Glaxosmithkline Biolog Sa |
Vaccine
|
CA2633772C
(en)
|
2005-12-22 |
2015-09-15 |
Ralph Leon Biemans |
Pneumococcal polysaccharide conjugate vaccine
|
US7540860B2
(en)
*
|
2006-01-23 |
2009-06-02 |
Keith Stamler |
Wound irrigation splashback shield
|
CA2681668C
(en)
|
2006-03-23 |
2014-04-01 |
Michael S. Singer |
Compositions comprising prostaglandin f2-alpha analogs and methods for reducing body fat
|
KR101541383B1
(ko)
|
2006-03-30 |
2015-08-03 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
면역원성 조성물
|
CA2648099C
(en)
|
2006-03-31 |
2012-05-29 |
The Brigham And Women's Hospital, Inc |
System for targeted delivery of therapeutic agents
|
CA2652280C
(en)
|
2006-05-15 |
2014-01-28 |
Massachusetts Institute Of Technology |
Polymers for functional particles
|
US7789856B2
(en)
*
|
2006-05-15 |
2010-09-07 |
Hillios Christopher H |
Injection aid and stability disk for syringe or insulin pen
|
US8361019B2
(en)
|
2006-05-15 |
2013-01-29 |
Hillios Christopher H |
Injection aid and stability disk for syringe or insulin pen
|
EP3045532A1
(de)
|
2006-06-02 |
2016-07-20 |
President and Fellows of Harvard College |
Neugestaltung von proteinoberflächen
|
WO2007150030A2
(en)
|
2006-06-23 |
2007-12-27 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
MX2009000660A
(es)
|
2006-07-17 |
2009-04-08 |
Glaxosmithkline Biolog Sa |
Vacuna de influenza.
|
SI2043682T1
(sl)
|
2006-07-17 |
2014-07-31 |
Glaxosmithkline Biologicals S.A. |
Influenčno cepivo
|
WO2008021367A2
(en)
|
2006-08-11 |
2008-02-21 |
President And Fellows Of Harvard College |
Moenomycin biosynthesis-related compositions and methods of use thereof
|
JO3598B1
(ar)
|
2006-10-10 |
2020-07-05 |
Infinity Discovery Inc |
الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
|
CA2664619C
(en)
|
2006-10-12 |
2012-12-11 |
Glaxosmithkline Biologicals S.A. |
Immunogenic compositions comprising an oil-in-water emulsion adjuvant containing a reduced amount of squalene, tocol and an emulsifying agent
|
EP2086582B1
(de)
|
2006-10-12 |
2012-11-14 |
GlaxoSmithKline Biologicals s.a. |
Impfstoff mit einem öl-in-wasser-emulsionshilfsstoff
|
MX2009005727A
(es)
|
2006-12-01 |
2009-08-27 |
Anterios Inc |
Nanoparticulas de entidad anfifilica.
|
EP2474525B1
(de)
|
2006-12-26 |
2020-04-15 |
Lantheus Medical Imaging, Inc. |
Liganden zur Bildgebung der kardialen Innervation
|
PT2118123E
(pt)
|
2007-01-31 |
2016-02-10 |
Harvard College |
Péptidos de p53 estabilizados e suas utilizações
|
EP2134830A2
(de)
|
2007-02-09 |
2009-12-23 |
Massachusetts Institute of Technology |
Oszillations-zellkultur-bioreaktor
|
CN100457206C
(zh)
*
|
2007-03-07 |
2009-02-04 |
中国人民解放军第二军医大学 |
可调式搏动心肌内注入器
|
NZ579994A
(en)
|
2007-03-15 |
2011-09-30 |
Univ Florida |
Desferrithiocin polyether analogues useful in the treatment of pathological conditions responsive to chelation or sequestration of trivalent metal
|
US7960139B2
(en)
|
2007-03-23 |
2011-06-14 |
Academia Sinica |
Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
|
ES2430067T3
(es)
|
2007-03-28 |
2013-11-18 |
President And Fellows Of Harvard College |
Polipéptidos cosidos
|
US20090074828A1
(en)
|
2007-04-04 |
2009-03-19 |
Massachusetts Institute Of Technology |
Poly(amino acid) targeting moieties
|
AR066405A1
(es)
|
2007-04-20 |
2009-08-19 |
Glaxosmithkline Biolog Sa |
Vacuna
|
EP2139543B1
(de)
|
2007-04-23 |
2018-06-06 |
Sid Technologies LLC |
Vorrichtungen für intradermale injektion
|
US8524444B2
(en)
|
2007-06-15 |
2013-09-03 |
President And Fellows Of Harvard College |
Methods and compositions for detections and modulating O-glycosylation
|
PL2167121T3
(pl)
|
2007-06-26 |
2016-01-29 |
Glaxosmithkline Biologicals Sa |
Szczepionka zawierająca koniugaty polisacharydu otoczkowego streptococcus pneumoniae
|
US8604004B2
(en)
|
2007-10-04 |
2013-12-10 |
President And Fellows Of Harvard College |
Moenomycin analogs, methods of synthesis, and uses thereof
|
US8439940B2
(en)
|
2010-12-22 |
2013-05-14 |
Cabochon Aesthetics, Inc. |
Dissection handpiece with aspiration means for reducing the appearance of cellulite
|
EP2630967A1
(de)
|
2007-10-12 |
2013-08-28 |
Massachusetts Institute of Technology |
Impfstoffnanotechnologie
|
CA2711330A1
(en)
|
2008-01-03 |
2009-07-16 |
Massachusetts Institute Of Technology |
Decoy influenza therapies
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
JP2008110260A
(ja)
*
|
2008-02-04 |
2008-05-15 |
Terumo Corp |
注射針用穿刺調整具およびそれを備えた注射針組立体
|
TW201000107A
(en)
|
2008-04-09 |
2010-01-01 |
Infinity Pharmaceuticals Inc |
Inhibitors of fatty acid amide hydrolase
|
PT2271360E
(pt)
|
2008-04-16 |
2015-12-07 |
Glaxosmithkline Biolog Sa |
Vacina
|
KR102080429B1
(ko)
|
2008-06-26 |
2020-02-21 |
안테리오스, 인코퍼레이티드 |
경피 운반
|
JP5986745B2
(ja)
|
2008-07-15 |
2016-09-06 |
アカデミア シニカAcademia Sinica |
Ptfe様のアルミニウム・コート・ガラススライド上のグリカンアレイおよび関連する方法
|
WO2010010488A1
(en)
*
|
2008-07-21 |
2010-01-28 |
Wockhardt Research Centre |
Device for attachment to a needle assembly to vary the length of the needle being exposed
|
EP2356139A4
(de)
|
2008-07-23 |
2013-01-09 |
Harvard College |
Ligieren zusammengehefteter polypeptide
|
US9206223B2
(en)
|
2008-09-22 |
2015-12-08 |
Aileron Therapeutics, Inc. |
Methods for preparing purified polypeptide compositions
|
US8343497B2
(en)
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
US8343498B2
(en)
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
JP5713913B2
(ja)
*
|
2008-11-07 |
2015-05-07 |
ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company |
薬剤の注射を容易にするシリンジ筐体
|
US9974844B2
(en)
|
2008-11-17 |
2018-05-22 |
The Regents Of The University Of Michigan |
Cancer vaccine compositions and methods of using the same
|
WO2010064211A2
(en)
*
|
2008-12-04 |
2010-06-10 |
Nanopass Technologies Ltd. |
Intradermal mini-needle interface and associated devices and methods
|
EP2373365B1
(de)
*
|
2008-12-08 |
2014-04-23 |
Sid Technologies LLC |
Ausrichtung einer nadel in einem intradermalen injektionsgerät
|
WO2010077806A1
(en)
|
2008-12-15 |
2010-07-08 |
Greenlight Biosciences, Inc. |
Methods for control of flux in metabolic pathways
|
CA2744088A1
(en)
|
2009-01-14 |
2010-07-22 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
TWI449551B
(zh)
|
2009-01-30 |
2014-08-21 |
Terumo Corp |
注射針組合體以及藥劑注射裝置
|
JP2012525146A
(ja)
|
2009-04-28 |
2012-10-22 |
プレジデント アンド フェロウズ オブ ハーバード カレッジ |
細胞透過のための過剰に荷電されたタンパク質
|
US8927551B2
(en)
|
2009-05-18 |
2015-01-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
US9149465B2
(en)
|
2009-05-18 |
2015-10-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
US8765735B2
(en)
|
2009-05-18 |
2014-07-01 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
US8957075B2
(en)
|
2009-06-01 |
2015-02-17 |
President And Fellows Of Harvard College |
O-GlcNAc transferase inhibitors and uses thereof
|
BR112012000867A2
(pt)
|
2009-07-13 |
2019-09-24 |
Harvard College |
"polipeptídeos bifuncional costurado e uso do mesmo"
|
EP2456491B1
(de)
|
2009-07-23 |
2017-04-19 |
Sid Technologies LLC |
Intradermaler injektionsadapter
|
GB0913681D0
(en)
|
2009-08-05 |
2009-09-16 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
US9358064B2
(en)
|
2009-08-07 |
2016-06-07 |
Ulthera, Inc. |
Handpiece and methods for performing subcutaneous surgery
|
US11096708B2
(en)
|
2009-08-07 |
2021-08-24 |
Ulthera, Inc. |
Devices and methods for performing subcutaneous surgery
|
WO2011038049A1
(en)
|
2009-09-22 |
2011-03-31 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
EP2483307A1
(de)
|
2009-09-29 |
2012-08-08 |
Fraunhofer USA, Inc. |
Influenza-hämagglutinin-antikörper, zusammensetzungen daraus und zugehörige verfahren
|
JP5667571B2
(ja)
|
2009-09-30 |
2015-02-12 |
テルモ株式会社 |
注射針組立体及び薬剤注射装置
|
GB0919117D0
(en)
|
2009-10-30 |
2009-12-16 |
Glaxosmithkline Biolog Sa |
Process
|
US11377485B2
(en)
|
2009-12-02 |
2022-07-05 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
US10087236B2
(en)
|
2009-12-02 |
2018-10-02 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
WO2011094445A1
(en)
|
2010-01-27 |
2011-08-04 |
Massachusetts Institute Of Technology |
Engineered polypeptide agents for targeted broad spectrum influenza neutralization
|
RU2569061C2
(ru)
|
2010-02-03 |
2015-11-20 |
Инфинити Фармасьютикалз, Инк. |
Ингибиторы амид-гидролазы жирных кислот
|
EA025443B1
(ru)
|
2010-03-08 |
2016-12-30 |
Слоан-Кеттеринг Институт Фор Кэнсер |
ПРИМЕНЕНИЕ В КАЧЕСТВЕ ИНГИБИТОРА КИНАЗЫ Cdc7 ГРАНАТИЦИНА B
|
GB201003922D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
GB201003920D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Method of treatment
|
EP2544734B1
(de)
|
2010-03-12 |
2016-03-09 |
Sid Technologies LLC |
Anordnung zur verwendung mit einer spritze
|
EP2550285B1
(de)
|
2010-03-22 |
2017-07-19 |
President and Fellows of Harvard College |
Trioxacarcine und deren verwendungen
|
US10338069B2
(en)
|
2010-04-12 |
2019-07-02 |
Academia Sinica |
Glycan arrays for high throughput screening of viruses
|
US8450350B2
(en)
|
2010-05-05 |
2013-05-28 |
Infinity Pharmaceuticals, Inc. |
Triazoles as inhibitors of fatty acid synthase
|
CA2798330A1
(en)
|
2010-05-05 |
2011-11-10 |
Infinity Pharmaceuticals, Inc. |
Tetrazolones as inhibitors of fatty acid synthase
|
EP2566953B1
(de)
|
2010-05-07 |
2019-01-02 |
Greenlight Biosciences, Inc. |
Verfahren zur flusssteuerung bei stoffwechselwegen druch enzymumpositionierung
|
KR20170042373A
(ko)
|
2010-05-11 |
2017-04-18 |
랜티우스 메디컬 이메징, 인크. |
영상화제의 합성 및 사용을 위한 조성물, 방법 및 시스템
|
EP2571875A4
(de)
|
2010-05-14 |
2013-10-30 |
Dana Farber Cancer Inst Inc |
Zusammensetzungen für männliches verhütungsmittel und verfahren zur verwendung
|
ES2664872T3
(es)
|
2010-06-18 |
2018-04-23 |
Taiho Pharmaceutical Co., Ltd |
Moduladores PRPK-TPRKB y sus usos
|
US8822663B2
(en)
|
2010-08-06 |
2014-09-02 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
KR20180058866A
(ko)
|
2010-08-13 |
2018-06-01 |
에일러론 테라퓨틱스 인코포레이티드 |
펩티도미메틱 거대고리
|
CA2809284C
(en)
|
2010-08-31 |
2021-02-23 |
Greenlight Biosciences, Inc. |
Methods for control of flux in metabolic pathways through protease manipulation
|
JP2013541528A
(ja)
|
2010-09-21 |
2013-11-14 |
マサチューセッツ インスティテュート オブ テクノロジー |
ヒト適応haポリペプチド、ワクチン、およびインフルエンザの処置
|
WO2012040459A2
(en)
|
2010-09-22 |
2012-03-29 |
President And Fellows Of Harvard College |
Beta-catenin targeting peptides and uses thereof
|
PT3590949T
(pt)
|
2010-10-01 |
2022-08-02 |
Modernatx Inc |
Ácidos ribonucleicos contendo n1-metilpseudouracilos e suas utilizações
|
CA2813078A1
(en)
|
2010-10-04 |
2012-04-12 |
Massachusetts Institute Of Technology |
Hemagglutinin polypeptides, and reagents and methods relating thereto
|
CN103298474B
(zh)
|
2010-11-10 |
2016-06-29 |
无限药品股份有限公司 |
杂环化合物及其用途
|
AR084824A1
(es)
|
2011-01-10 |
2013-06-26 |
Intellikine Inc |
Procesos para preparar isoquinolinonas y formas solidas de isoquinolinonas
|
JP5778781B2
(ja)
|
2011-01-19 |
2015-09-16 |
トポカイン セラピューティックス, インコーポレイテッド |
代謝症候群を治療する方法および組成物
|
EP2489379B1
(de)
|
2011-01-21 |
2020-09-23 |
SID Technologies, LLC |
Intradermaler Stiftadapter
|
US20120328701A1
(en)
|
2011-01-24 |
2012-12-27 |
Anterios, Inc. |
Nanoparticle compositions, formulations thereof, and uses therefor
|
US20120328549A1
(en)
|
2011-01-24 |
2012-12-27 |
Anterios, Inc. |
Oil compositions
|
CN109464393A
(zh)
|
2011-01-24 |
2019-03-15 |
安特里奥公司 |
纳米颗粒组合物
|
CN103889219A
(zh)
|
2011-03-03 |
2014-06-25 |
特萨斯制药有限责任公司 |
包含C16:1n7-棕榈油酸酯的组合物和方法
|
GB201103836D0
(en)
|
2011-03-07 |
2011-04-20 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
US9193767B2
(en)
|
2011-03-30 |
2015-11-24 |
Brown University |
Enopeptins, uses thereof, and methods of synthesis thereto
|
US8710200B2
(en)
|
2011-03-31 |
2014-04-29 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids encoding a modified erythropoietin and their expression
|
JP5894582B2
(ja)
*
|
2011-04-28 |
2016-03-30 |
テルモ株式会社 |
注射針組立体及び薬剤注射装置
|
CN103501845B
(zh)
*
|
2011-04-28 |
2016-02-10 |
泰尔茂株式会社 |
注射针组装体及药剂注射装置
|
CA2834834A1
(en)
|
2011-05-17 |
2012-11-22 |
Glaxosmithkline Biologicals S.A. |
Vaccine against streptococcus pneumoniae
|
US9845327B2
(en)
|
2011-06-22 |
2017-12-19 |
The General Hospital Corporation |
Treatment of proteinopathies
|
CA2842190A1
(en)
|
2011-07-19 |
2013-01-24 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
US8969363B2
(en)
|
2011-07-19 |
2015-03-03 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
WO2013016193A2
(en)
|
2011-07-22 |
2013-01-31 |
Massachusetts Istitute Of Technology |
Activators of class i histone deacetlyases (hdacs) and uses thereof
|
US10137244B2
(en)
|
2011-08-01 |
2018-11-27 |
Alcyone Lifesciences, Inc. |
Microfluidic drug delivery devices with venturi effect
|
RU2014111823A
(ru)
|
2011-08-29 |
2015-10-10 |
Инфинити Фармасьютикалз, Инк. |
Гетероциклические соединения и их применения
|
TWI568714B
(zh)
|
2011-09-09 |
2017-02-01 |
藍瑟斯醫學影像公司 |
用於合成及使用造影劑之組合物、方法及系統
|
CN104093848A
(zh)
|
2011-09-09 |
2014-10-08 |
绿光生物科学公司 |
碳青霉烯(carbapenem)的无细胞制备
|
EP2755693A4
(de)
|
2011-09-12 |
2015-05-20 |
Moderna Therapeutics Inc |
Manipulierte nukleinsäuren und anwendungsverfahren dafür
|
WO2013049332A1
(en)
|
2011-09-29 |
2013-04-04 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of monoacylglycerol lipase and methods of their use
|
SG11201401196WA
(en)
|
2011-10-03 |
2014-05-29 |
Moderna Therapeutics Inc |
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
|
BR112014009418A2
(pt)
|
2011-10-18 |
2017-04-18 |
Aileron Therapeutics Inc |
macrociclos peptidomiméticos
|
EP2589401A1
(de)
|
2011-11-04 |
2013-05-08 |
Fiderm S.r.l. (Ricerca e Technogie in Scienze Dermatologiche) |
Vorrichtung zur Steuerung der Tiefe und zur Reduzierung des Schmerzes von Injektionen
|
ES2904536T3
(es)
|
2011-11-07 |
2022-04-05 |
Lilly Co Eli |
Dispositivos de inyección con mejoras ergonómicas
|
WO2013074986A1
(en)
|
2011-11-17 |
2013-05-23 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of c-jun-n-terminal kinase (jnk)
|
GB201119999D0
(en)
|
2011-11-20 |
2012-01-04 |
Glaxosmithkline Biolog Sa |
Vaccine
|
GB201120000D0
(en)
|
2011-11-20 |
2012-01-04 |
Glaxosmithkline Biolog Sa |
Vaccine
|
AU2012352180A1
(en)
|
2011-12-16 |
2014-07-31 |
Moderna Therapeutics, Inc. |
Modified nucleoside, nucleotide, and nucleic acid compositions
|
US8426471B1
(en)
|
2011-12-19 |
2013-04-23 |
Topokine Therapeutics, Inc. |
Methods and compositions for reducing body fat and adipocytes
|
US8927500B2
(en)
|
2012-02-15 |
2015-01-06 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
US8987414B2
(en)
|
2012-02-15 |
2015-03-24 |
Aileron Therapeutics, Inc. |
Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
|
ITMO20120040A1
(it)
*
|
2012-02-16 |
2013-08-17 |
Lameplast Spa |
Dispositivo per il controllo della profondita' di penetrazione di un ago per iniezioni
|
GB201205189D0
(en)
|
2012-03-23 |
2012-05-09 |
Glaxosmithkline Biolog Sa |
Novel medical use
|
US9273084B2
(en)
|
2012-04-06 |
2016-03-01 |
President And Fellows Of Harvard College |
Moenomycin analogs, methods of synthesis, and uses thereof
|
EP2850091A1
(de)
|
2012-04-06 |
2015-03-25 |
President and Fellows of Harvard College |
Verfahren und verbindungen zur identifizierung von glycosyltransferaseinhibitoren
|
EP2850090B1
(de)
|
2012-04-06 |
2018-10-03 |
President and Fellows of Harvard College |
Chemoenzymatische verfahren zur synthetisierung von moenomycin-analoga
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
US10130714B2
(en)
|
2012-04-14 |
2018-11-20 |
Academia Sinica |
Enhanced anti-influenza agents conjugated with anti-inflammatory activity
|
EP2841098A4
(de)
|
2012-04-23 |
2016-03-02 |
Allertein Therapeutics Llc |
Nanopartikel zur behandlung von allergien
|
WO2013169377A1
(en)
|
2012-05-10 |
2013-11-14 |
Massachusetts Institute Of Technology |
Agents for influenza neutralization
|
US20140037680A1
(en)
|
2012-08-06 |
2014-02-06 |
Glaxosmithkline Biologicals, S.A. |
Novel method
|
CA2879939A1
(en)
|
2012-08-06 |
2014-02-13 |
Glaxosmithkline Biologicals S.A. |
Novel method
|
AU2013203000B9
(en)
|
2012-08-10 |
2017-02-02 |
Lantheus Medical Imaging, Inc. |
Compositions, methods, and systems for the synthesis and use of imaging agents
|
JP6302909B2
(ja)
|
2012-08-18 |
2018-03-28 |
アカデミア シニカAcademia Sinica |
シアリダーゼの同定および画像化のための細胞透過性プローブ
|
EP2705866B1
(de)
*
|
2012-09-11 |
2018-03-21 |
Karim-Frédéric Marti |
Vorrichtung zur Schmerzreduzierung bei der Einführung einer Spritzennadel in die Haut
|
JP6506166B2
(ja)
|
2012-09-26 |
2019-04-24 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
プロリンロックドステープルドペプチドおよびその用途
|
WO2014055564A1
(en)
|
2012-10-01 |
2014-04-10 |
President And Fellows Of Harvard College |
Stabilized polypeptide insulin receptor modulators
|
PL2909204T3
(pl)
|
2012-10-12 |
2019-07-31 |
The Broad Institute, Inc. |
Inhibitory GSK3 i sposoby ich stosowania
|
WO2014063068A1
(en)
|
2012-10-18 |
2014-04-24 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 (cdk7)
|
US10000483B2
(en)
|
2012-10-19 |
2018-06-19 |
Dana-Farber Cancer Institute, Inc. |
Bone marrow on X chromosome kinase (BMX) inhibitors and uses thereof
|
US9758522B2
(en)
|
2012-10-19 |
2017-09-12 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged small molecules as inducers of protein degradation
|
JP6526563B2
(ja)
|
2012-11-01 |
2019-06-05 |
エイルロン セラピューティクス,インコーポレイテッド |
二置換アミノ酸ならびにその調製および使用の方法
|
LT2914296T
(lt)
|
2012-11-01 |
2018-09-25 |
Infinity Pharmaceuticals, Inc. |
Vėžio gydymas, panaudojant p13 kinazės izoformos moduliatorius
|
EP2917203B1
(de)
|
2012-11-02 |
2019-04-03 |
Dana-Farber Cancer Institute, Inc. |
Verfahren zur identifizierung von myc inhibitoren
|
KR101651448B1
(ko)
|
2012-11-21 |
2016-08-26 |
토포카인 쎄라퓨틱스, 인코포레이티드 |
체지방을 국소적으로 증가시키는 방법 및 조성물
|
JP6144355B2
(ja)
|
2012-11-26 |
2017-06-07 |
モデルナティエックス インコーポレイテッドModernaTX,Inc. |
化学修飾mRNA
|
US9775915B2
(en)
|
2012-11-26 |
2017-10-03 |
President And Fellows Of Harvard College |
Trioxacarcins, trioxacarcin-antibody conjugates, and uses thereof
|
EP3868541A1
(de)
|
2012-12-18 |
2021-08-25 |
Alcyone Lifesciences, Inc. |
Vorrichtungen und verfahren zur verminderung oder verhinderung von rückstrom in einem abgabesystem
|
WO2014100716A1
(en)
|
2012-12-21 |
2014-06-26 |
Epizyme, Inc. |
Prmt5 inhibitors and uses thereof
|
JP6678455B2
(ja)
|
2012-12-21 |
2020-04-08 |
エピザイム,インコーポレイティド |
Prmt5阻害剤およびその使用
|
JP2016505000A
(ja)
|
2012-12-21 |
2016-02-18 |
エピザイム,インコーポレイティド |
Prmt5阻害剤およびその使用
|
WO2014100730A1
(en)
|
2012-12-21 |
2014-06-26 |
Epizyme, Inc. |
Prmt5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof
|
CA2897941A1
(en)
|
2013-01-17 |
2014-07-24 |
Moderna Therapeutics, Inc. |
Signal-sensor polynucleotides for the alteration of cellular phenotypes
|
JP6518597B2
(ja)
|
2013-02-07 |
2019-05-22 |
マサチューセッツ インスティテュート オブ テクノロジー |
H5インフルエンザのヒトへの適応
|
US20160024181A1
(en)
|
2013-03-13 |
2016-01-28 |
Moderna Therapeutics, Inc. |
Long-lived polynucleotide molecules
|
US10081654B2
(en)
|
2013-03-13 |
2018-09-25 |
President And Fellows Of Harvard College |
Stapled and stitched polypeptides and uses thereof
|
US9597463B2
(en)
|
2013-03-14 |
2017-03-21 |
Boston Scientific Scimed, Inc. |
Injection devices with controllable depth adjustability and methods of use
|
WO2014151386A1
(en)
|
2013-03-15 |
2014-09-25 |
Infinity Pharmaceuticals, Inc. |
Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
|
US9345618B2
(en)
*
|
2013-03-26 |
2016-05-24 |
Crt Technology Inc. |
Ocular device
|
JP2016516754A
(ja)
|
2013-04-03 |
2016-06-09 |
アラーテイン・セラピューティクス・リミテッド・ライアビリティ・カンパニーAllertein Therapeutics, LLC |
新規のナノ粒子組成物
|
MX2015014026A
(es)
|
2013-04-04 |
2016-08-03 |
Harvard College |
Macrolidos y metodos para su preparacion y uso.
|
US9381253B2
(en)
|
2013-04-09 |
2016-07-05 |
Massachusetts Institute Of Technology |
Drug delivery polymer and uses thereof
|
US9474865B2
(en)
|
2013-04-25 |
2016-10-25 |
West Pharmaceutical Services, Inc. |
Needle shield for disposable syringe with annular ring
|
US10301359B2
(en)
|
2013-04-30 |
2019-05-28 |
Massachusetts Institute Of Technology |
Human adaptation of H3 influenza
|
US9315472B2
(en)
|
2013-05-01 |
2016-04-19 |
Massachusetts Institute Of Technology |
1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
|
NO2753788T3
(de)
|
2013-05-10 |
2018-06-16 |
|
|
AU2014273946B2
(en)
|
2013-05-30 |
2020-03-12 |
Infinity Pharmaceuticals, Inc. |
Treatment of cancers using PI3 kinase isoform modulators
|
US10526375B2
(en)
|
2013-06-05 |
2020-01-07 |
Massachusetts Institute Of Technology |
Human Adaptation of H7 HA
|
JP6469661B2
(ja)
|
2013-06-11 |
2019-02-13 |
カラ ファーマシューティカルズ インコーポレイテッド |
尿素誘導体及びその使用
|
AU2014278005B2
(en)
|
2013-06-14 |
2018-11-22 |
President And Fellows Of Harvard College |
Stabilized polypeptide insulin receptor modulators
|
CN105517617B
(zh)
|
2013-06-17 |
2019-06-21 |
亚克安娜生命科学有限公司 |
用于保护导管末梢的方法和装置以及用于微导管的立体定向固定装置
|
WO2014210397A1
(en)
|
2013-06-26 |
2014-12-31 |
Academia Sinica |
Rm2 antigens and use thereof
|
EP3013347B1
(de)
|
2013-06-27 |
2019-12-11 |
Academia Sinica |
Glykankonjugate und verwendung davon
|
KR20160034379A
(ko)
|
2013-07-25 |
2016-03-29 |
다나-파버 캔서 인스티튜트 인크. |
전사 인자의 억제제 및 그의 용도
|
EP3027259B1
(de)
|
2013-07-31 |
2019-03-13 |
Alcyone Lifesciences, Inc. |
Systeme und verfahren zur wirkstofffreisetzung, behandlung und überwachung
|
WO2015018806A1
(en)
|
2013-08-05 |
2015-02-12 |
Glaxosmithkline Biologicals S.A. |
Combination immunogenic compositions
|
JP6483687B2
(ja)
|
2013-08-05 |
2019-03-13 |
グリーンライト バイオサイエンシーズ インコーポレーテッドGreenlight Biosciences,Inc. |
プロテアーゼ切断部位を有する操作されたタンパク質
|
EP3041484B1
(de)
|
2013-09-06 |
2021-03-03 |
Academia Sinica |
Humane inkt-zell-aktivierung mittels glykolipiden mit veränderten glycosylgruppen
|
CN104436157A
(zh)
|
2013-09-23 |
2015-03-25 |
恩金生物有限公司 |
流感疫苗和治疗
|
WO2015051241A1
(en)
|
2013-10-04 |
2015-04-09 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
MY175778A
(en)
|
2013-10-04 |
2020-07-08 |
Infinity Pharmaceuticals Inc |
Heterocyclic compounds and uses thereof
|
WO2015057894A1
(en)
|
2013-10-15 |
2015-04-23 |
Massachusetts Institute Of Technology |
Methods for treating polycystic kidney disease and polycystic liver disease
|
WO2015057958A2
(en)
|
2013-10-16 |
2015-04-23 |
Massachusetts Institute Of Technology |
Enterobactin conjugates and uses thereof
|
AU2014337044A1
(en)
|
2013-10-18 |
2016-05-05 |
Dana-Farber Cancer Institute, Inc. |
Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)
|
WO2015061204A1
(en)
|
2013-10-21 |
2015-04-30 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
MX355330B
(es)
|
2013-11-01 |
2018-04-16 |
Kala Pharmaceuticals Inc |
Formas cristalinas de compuestos terapeuticos y sus usos.
|
CN105849110B
(zh)
|
2013-11-08 |
2019-08-02 |
达纳-法伯癌症研究所有限公司 |
使用溴结构域和额外终端(bet)蛋白抑制剂的用于癌症的组合疗法
|
RU2016126503A
(ru)
|
2013-12-24 |
2018-01-30 |
Президент Энд Феллоус Оф Гарвард Колледж |
Аналоги кортистатина, их синтез и применения
|
US10150818B2
(en)
|
2014-01-16 |
2018-12-11 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
CA2937123A1
(en)
|
2014-01-16 |
2015-07-23 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
US10793571B2
(en)
|
2014-01-31 |
2020-10-06 |
Dana-Farber Cancer Institute, Inc. |
Uses of diazepane derivatives
|
MX2016011160A
(es)
|
2014-02-28 |
2017-04-27 |
Tensha Therapeutics Inc |
Tratamiento de afecciones asociadas con la hiperinsulinemia.
|
MX2016011517A
(es)
|
2014-03-07 |
2017-04-13 |
Univ Arizona |
Peptidos de crmp2 no narcoticos que seleccionan como diana canales de sodio para el dolor cronico.
|
SG11201607705XA
(en)
|
2014-03-19 |
2016-10-28 |
Infinity Pharmaceuticals Inc |
Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
|
EP3129767B1
(de)
|
2014-03-27 |
2021-09-01 |
Academia Sinica |
Reaktive markierungsverbindungen und ihre verwendungen
|
EP3122375B1
(de)
|
2014-03-28 |
2021-03-03 |
University of Washington through its Center for Commercialization |
Impfungen gegen brust- und eierstockkrebs
|
WO2015168079A1
(en)
|
2014-04-29 |
2015-11-05 |
Infinity Pharmaceuticals, Inc. |
Pyrimidine or pyridine derivatives useful as pi3k inhibitors
|
WO2015168380A1
(en)
|
2014-04-30 |
2015-11-05 |
Massachusetts Institute Of Technology |
Siderophore-based immunization against gram-negative bacteria
|
IL288147B2
(en)
|
2014-05-21 |
2024-03-01 |
Harvard College |
RAS inhibitory peptides and their uses
|
EP3149037A4
(de)
|
2014-05-27 |
2018-01-10 |
Academia Sinica |
Anti-her2-glykoantikörper und verwendungen davon
|
KR20170003720A
(ko)
|
2014-05-27 |
2017-01-09 |
아카데미아 시니카 |
항-cd20 글리코항체 및 이의 용도
|
US10118969B2
(en)
|
2014-05-27 |
2018-11-06 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
KR20170005142A
(ko)
|
2014-05-27 |
2017-01-11 |
아카데미아 시니카 |
증진된 항체 효능을 위한 범용 당형태에 관한 조성물 및 방법
|
TWI732738B
(zh)
|
2014-05-28 |
2021-07-11 |
中央研究院 |
抗TNF-α醣抗體及其用途
|
EP3888676A1
(de)
|
2014-06-13 |
2021-10-06 |
GlaxoSmithKline Biologicals S.A. |
Immunogene kombinationen
|
AP2017009690A0
(en)
|
2014-06-19 |
2017-01-31 |
Ariad Pharma Inc |
Heteroaryl compounds for kinase inhibition
|
WO2015200425A1
(en)
|
2014-06-27 |
2015-12-30 |
Topokine Therapeutics, Inc. |
Topical dosage regimen
|
AU2015283805B2
(en)
|
2014-06-30 |
2021-02-25 |
Murdoch Childrens Research Institute |
Helicobacter therapeutic
|
EP3164379A1
(de)
|
2014-07-02 |
2017-05-10 |
Massachusetts Institute of Technology |
Lipidoide aus polyaminfettsäure und verwendungen davon
|
CN106715458A
(zh)
|
2014-07-18 |
2017-05-24 |
华盛顿大学 |
癌症疫苗组合物及其使用方法
|
WO2016019160A1
(en)
*
|
2014-07-30 |
2016-02-04 |
University Of Kansas |
Cannula for external drainage of subretinal fluid
|
US10736966B2
(en)
|
2014-08-12 |
2020-08-11 |
Massachusetts Institute Of Technology |
Brush-poly (glycoamidoamine)-lipids and uses thereof
|
KR102422375B1
(ko)
|
2014-09-08 |
2022-07-18 |
아카데미아 시니카 |
당지질을 사용한 인간 iNKT 세포 활성화
|
CN107106642B
(zh)
|
2014-09-24 |
2021-02-26 |
艾瑞朗医疗公司 |
拟肽大环化合物及其制剂
|
JP2017533889A
(ja)
|
2014-09-24 |
2017-11-16 |
エルロン・セラピューティクス・インコーポレイテッドAileron Therapeutics,Inc. |
ペプチド模倣大環状分子およびその使用
|
WO2016054491A1
(en)
|
2014-10-03 |
2016-04-07 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
US10385078B2
(en)
|
2014-10-21 |
2019-08-20 |
Ariad Pharmaceuticals, Inc. |
Crystalline forms of 5-chloro-N4-[-2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-YL) piperidin-1-YL]phenyl}pyrimidine-2,4-diamine
|
EP3212654B1
(de)
|
2014-10-27 |
2020-04-08 |
Tensha Therapeutics, Inc. |
Bromdomänenhemmer
|
US20180015101A1
(en)
|
2014-10-28 |
2018-01-18 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Compositions and methods for antigen-specific tolerance
|
EP3041948B1
(de)
|
2014-11-10 |
2019-01-09 |
Modernatx, Inc. |
Alternative nukleinsäuremoleküle mit reduziertem uracilgehalt und verwendungen davon
|
US10253045B2
(en)
|
2014-11-26 |
2019-04-09 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of a therapeutic compound and uses thereof
|
EP3230272B1
(de)
|
2014-12-10 |
2020-08-19 |
Kala Pharmaceuticals, Inc. |
1-amino-triazol(1,5-a)pyridin-substituiertes harnstoffderivat und verwendungen davon
|
JP7358029B2
(ja)
|
2014-12-23 |
2023-10-10 |
スローン - ケタリング・インスティテュート・フォー・キャンサー・リサーチ |
グラナチシンbの多形体
|
US10495645B2
(en)
|
2015-01-16 |
2019-12-03 |
Academia Sinica |
Cancer markers and methods of use thereof
|
US9975965B2
(en)
|
2015-01-16 |
2018-05-22 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
WO2016118191A1
(en)
|
2015-01-24 |
2016-07-28 |
Academia Sinica |
Novel glycan conjugates and methods of use thereof
|
US10806396B2
(en)
|
2015-01-26 |
2020-10-20 |
Alcyone Lifesciences, Inc. |
Drug delivery methods with tracer
|
CA2979847A1
(en)
|
2015-03-20 |
2016-09-29 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
AU2016243529B2
(en)
|
2015-03-27 |
2021-03-25 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinases
|
BR112017020690A2
(pt)
|
2015-03-30 |
2018-06-26 |
Greenlight Biosciences Inc |
produção livre de células de ácido ribonucleico
|
CA2984250A1
(en)
|
2015-04-27 |
2016-11-03 |
University Of Florida Research Foundation, Incorporated |
Metabolically programmed metal chelators and uses thereof
|
WO2016178591A2
(en)
|
2015-05-05 |
2016-11-10 |
Gene Predit, Sa |
Genetic markers and treatment of male obesity
|
RS64331B1
(sr)
|
2015-06-19 |
2023-08-31 |
Massachusetts Inst Technology |
Alkenil supstituisani 2,5-piperazindioni i njihova primena u sastavima za isporuku agensa u organizam ili ćeliju subjekta
|
WO2017004548A1
(en)
|
2015-07-01 |
2017-01-05 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
CN108368161A
(zh)
|
2015-09-10 |
2018-08-03 |
艾瑞朗医疗公司 |
作为mcl-1调节剂的拟肽大环化合物
|
PT3350333T
(pt)
|
2015-09-17 |
2022-03-02 |
Modernatx Inc |
Polinucleótidos contendo uma região de cauda estabilizadora
|
EP4286012A2
(de)
|
2015-09-17 |
2023-12-06 |
ModernaTX, Inc. |
Verbindungen und zusammensetzungen zur intrazellulären verabreichung von therapeutischen wirkstoffen
|
EP3355882A1
(de)
|
2015-10-01 |
2018-08-08 |
Kythera Biopharmaceuticals, Inc. |
Zusammensetzungen mit einem statin zur verwendung in verfahren zur adipolyse
|
GB201518684D0
(en)
|
2015-10-21 |
2015-12-02 |
Glaxosmithkline Biolog Sa |
Vaccine
|
CA2998651C
(en)
|
2015-11-28 |
2021-01-19 |
Biopreme Medical Technologies Inc. |
Negative pressure injection device
|
EP4036079A3
(de)
|
2015-12-22 |
2022-09-28 |
ModernaTX, Inc. |
Verbindungen und zusammensetzungen zur intrazellulären verabreichung von wirkstoffen
|
CA3008680A1
(en)
|
2016-01-04 |
2017-07-13 |
Alcyone Lifesciences, Inc. |
Methods and devices for treating stroke
|
US10500351B2
(en)
|
2016-02-12 |
2019-12-10 |
Shawn Michael Michels |
Aid for subcutaneous tissue injection and process of effecting the injection with the aid
|
GB201603625D0
(en)
|
2016-03-02 |
2016-04-13 |
Glaxosmithkline Biolog Sa |
Novel influenza antigens
|
US10336784B2
(en)
|
2016-03-08 |
2019-07-02 |
Academia Sinica |
Methods for modular synthesis of N-glycans and arrays thereof
|
US10759806B2
(en)
|
2016-03-17 |
2020-09-01 |
Infinity Pharmaceuticals, Inc. |
Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors
|
WO2017167768A1
(en)
|
2016-03-28 |
2017-10-05 |
Glaxosmithkline Biologicals S.A. |
Novel vaccine composition
|
AU2017246458B2
(en)
|
2016-04-06 |
2022-08-11 |
Greenlight Biosciences, Inc. |
Cell-free production of ribonucleic acid
|
EA201892385A1
(ru)
|
2016-06-03 |
2019-06-28 |
Санофи Пастер Инк. |
Модификация сконструированных полипептидов гемагглютинина вируса гриппа
|
WO2017214337A1
(en)
|
2016-06-07 |
2017-12-14 |
Massachusetts Institute Of Technology |
Drug delivery polymers and uses thereof
|
WO2017214269A1
(en)
|
2016-06-08 |
2017-12-14 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
US20200069599A1
(en)
|
2016-06-14 |
2020-03-05 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
GB201610599D0
(en)
|
2016-06-17 |
2016-08-03 |
Glaxosmithkline Biologicals Sa |
Immunogenic Composition
|
EP3493837B1
(de)
|
2016-08-05 |
2022-08-31 |
Sanofi Pasteur, Inc. |
Polyvalente pneumokokken-polysaccharid-proteinkonjugatzusammensetzung
|
CA3031797A1
(en)
|
2016-08-05 |
2018-02-08 |
Sanofi Pasteur, Inc. |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
US10538592B2
(en)
|
2016-08-22 |
2020-01-21 |
Cho Pharma, Inc. |
Antibodies, binding fragments, and methods of use
|
US11583504B2
(en)
|
2016-11-08 |
2023-02-21 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
CN110198703A
(zh)
|
2016-11-21 |
2019-09-03 |
艾里奥治疗公司 |
大试剂的透皮递送
|
WO2018106738A1
(en)
|
2016-12-05 |
2018-06-14 |
Massachusetts Institute Of Technology |
Brush-arm star polymers, conjugates and particles, and uses thereof
|
EP3570918A1
(de)
*
|
2016-12-16 |
2019-11-27 |
H. Hoffnabb-La Roche Ag |
Abstandshalter für eine spritze
|
PT3596041T
(pt)
|
2017-03-15 |
2023-02-28 |
Modernatx Inc |
Compostos e composições para entrega intracelular de agentes terapêuticos
|
CA3055653A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Lipid nanoparticle formulation
|
EP3601326A4
(de)
|
2017-03-20 |
2020-12-16 |
The Broad Institute, Inc. |
Verbindungen und verfahren zur regulierung der insulinsekretion
|
EP3638678A1
(de)
|
2017-06-14 |
2020-04-22 |
Modernatx, Inc. |
Verbindungen und zusammensetzungen zur intrazellulären verabreichung von wirkstoffen
|
BR112019027387A8
(pt)
|
2017-06-23 |
2022-12-06 |
Univ Maryland |
Composições imunogênicas
|
WO2019013790A1
(en)
|
2017-07-12 |
2019-01-17 |
Curza Global, Llc |
ANTIMICROBIAL COMPOUNDS AND USES THEREOF
|
WO2019013789A1
(en)
|
2017-07-12 |
2019-01-17 |
Curza Global, Llc |
ANTIMICROBIAL COMPOUNDS
|
US11744801B2
(en)
|
2017-08-31 |
2023-09-05 |
Modernatx, Inc. |
Methods of making lipid nanoparticles
|
CA3078726A1
(en)
|
2017-10-11 |
2019-04-18 |
Greenlight Biosciences, Inc. |
Methods and compositions for nucleoside triphosphate and ribonucleic acid production
|
US11786477B2
(en)
|
2017-12-01 |
2023-10-17 |
North Carolina State University |
Fibrin particles and methods of making the same
|
GB201721582D0
(en)
|
2017-12-21 |
2018-02-07 |
Glaxosmithkline Biologicals Sa |
S aureus antigens and immunogenic compositions
|
GB201721576D0
(en)
|
2017-12-21 |
2018-02-07 |
Glaxosmithkline Biologicals Sa |
Hla antigens and glycoconjugates thereof
|
JP2022500452A
(ja)
|
2018-09-13 |
2022-01-04 |
エイリオン セラピューティクス, インコーポレイテッド |
プラスミノーゲンアクチベーターインヒビター1(plasminogen activator inhibitor 1)(PAI−1)阻害剤(inhibitor)の使用
|
CA3112558A1
(en)
|
2018-09-13 |
2020-03-19 |
Eirion Therapeutics, Inc. |
Plasminogen activator inhibitor 1 (pai-1) inhibitors and uses therefor
|
EP3853202A1
(de)
|
2018-09-19 |
2021-07-28 |
ModernaTX, Inc. |
Verbindungen und zusammensetzungen zur intrazellulären verabreichung von therapeutischen wirkstoffen
|
CN113271926A
(zh)
|
2018-09-20 |
2021-08-17 |
摩登纳特斯有限公司 |
脂质纳米颗粒的制备及其施用方法
|
BR112021009554A2
(pt)
|
2018-12-03 |
2021-08-17 |
Eirion Therapeutics, Inc. |
aplicação melhorada de agentes grandes
|
AU2020209167A1
(en)
|
2019-01-16 |
2021-08-12 |
Curza Global, Llc |
Antimicrobial compounds and methods
|
CA3126815A1
(en)
|
2019-01-16 |
2020-07-23 |
Curza Global, Llc |
Antimicrobial compounds and methods
|
SG11202108100PA
(en)
|
2019-01-31 |
2021-08-30 |
Modernatx Inc |
Methods of preparing lipid nanoparticles
|
WO2020168466A1
(en)
|
2019-02-19 |
2020-08-27 |
Stemirna Therapeutics Co., Ltd. |
Modified nucleoside and synthetic methods thereof
|
CN110101944A
(zh)
*
|
2019-05-13 |
2019-08-09 |
马飒飒 |
一种神经阻滞麻醉针定位装置
|
WO2020231983A1
(en)
|
2019-05-14 |
2020-11-19 |
Eirion Therapeutics, Inc. |
Delaying peak effect and/or extending duration of response
|
EP4003296A1
(de)
|
2019-07-31 |
2022-06-01 |
ModernaTX, Inc. |
Zusammensetzungen und verfahren zur abgabe von rna-interferenzmitteln an immunzellen
|
WO2021021729A1
(en)
|
2019-07-31 |
2021-02-04 |
Sanofi Pasteur Inc. |
Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same
|
US20230278987A1
(en)
|
2019-11-13 |
2023-09-07 |
Curza Global, Llc |
Antimicrobial Compounds and Methods
|
CN116133652A
(zh)
|
2020-01-31 |
2023-05-16 |
摩登纳特斯有限公司 |
制备脂质纳米粒子的方法
|
WO2021173965A1
(en)
|
2020-02-28 |
2021-09-02 |
Massachusetts Institute Of Technology |
Identification of variable influenza residues and uses thereof
|
WO2021231729A1
(en)
|
2020-05-13 |
2021-11-18 |
Sanofi |
Adjuvanted stabilized stem hemagglutinin nanoparticles and methods of using the same to induce broadly neutralizing antibodies against influenza
|
US20230174576A1
(en)
|
2020-10-30 |
2023-06-08 |
Xeno-Interface Inc. |
Beta-strand bridge peptide
|
EP4238567A1
(de)
|
2020-10-30 |
2023-09-06 |
Keio University |
Neuartige behandlung und prävention von erkrankungen im zusammenhang mit sarkopenie
|
TW202237068A
(zh)
|
2020-12-09 |
2022-10-01 |
美商建南德克公司 |
製備脂質奈米顆粒的高通量方法及其用途
|
US20220287983A1
(en)
|
2021-03-09 |
2022-09-15 |
Massachusetts Institute Of Technology |
Branched poly(-amino esters) for the delivery of nucleic acids
|
TW202313065A
(zh)
|
2021-05-28 |
2023-04-01 |
美商季卡尼醫療公司 |
用於治療遺傳疾病之化合物
|
BR112023027401A2
(pt)
|
2021-06-28 |
2024-03-12 |
Glaxosmithkline Biologicals Sa |
Antígenos do vírus influenza
|
IT202100020528A1
(it)
|
2021-07-30 |
2023-01-30 |
Fiderm Srl |
Dispositivo di regolazione della profondità di penetrazione di un ago per siringhe e siringa includente detto dispositivo
|
WO2023018817A1
(en)
|
2021-08-11 |
2023-02-16 |
Sanofi Pasteur Inc. |
Truncated influenza neuraminidase and methods of using the same
|
WO2023039108A1
(en)
|
2021-09-08 |
2023-03-16 |
Affinivax, Inc. |
Coronavirus vaccine
|
TW202333778A
(zh)
|
2021-10-08 |
2023-09-01 |
美商賽諾菲巴斯德公司 |
多價流感疫苗
|
WO2023081798A1
(en)
|
2021-11-05 |
2023-05-11 |
Sanofi Pasteur Inc. |
Multivalent influenza vaccines comprising recombinant hemagglutinin and neuraminidase and methods of using the same
|
WO2023079113A1
(en)
|
2021-11-05 |
2023-05-11 |
Sanofi |
Hybrid multivalent influenza vaccines comprising hemagglutinin and neuraminidase and methods of using the same
|
WO2023114889A1
(en)
|
2021-12-16 |
2023-06-22 |
Modernatx, Inc. |
Processes for preparing lipid nanoparticles
|
WO2023129963A1
(en)
|
2021-12-30 |
2023-07-06 |
Curza Global, Llc |
Antimicrobial compounds and methods
|
WO2023144206A1
(en)
|
2022-01-27 |
2023-08-03 |
Sanofi Pasteur |
Modified vero cells and methods of using the same for virus production
|
WO2023177577A1
(en)
|
2022-03-14 |
2023-09-21 |
Sanofi Pasteur Inc. |
Machine-learning techniques in protein design for vaccine generation
|
WO2023193002A1
(en)
|
2022-04-01 |
2023-10-05 |
Modernatx, Inc. |
Cross mixers for lipid nanoparticle production, and methods of operating the same
|
WO2023235380A1
(en)
|
2022-06-01 |
2023-12-07 |
Zikani Therapeutics, Inc. |
Macrolides for treating genetic diseases
|
WO2023250513A1
(en)
|
2022-06-24 |
2023-12-28 |
Zikani Therapeutics, Inc. |
13-membered macrolide compounds for treating diseases mediated by abnormal protein translation
|
WO2024026482A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Lipid nanoparticle compositions comprising surface lipid derivatives and related uses
|
WO2024026475A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Compositions for delivery to hematopoietic stem and progenitor cells (hspcs) and related uses
|
WO2024026487A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Lipid nanoparticle compositions comprising phospholipid derivatives and related uses
|
WO2024049994A1
(en)
|
2022-09-01 |
2024-03-07 |
Zikani Therapeutics, Inc. |
Treatment of familial adenomatous polyopsis using a 13-membered macrolide
|